Webinars

timely and informative programs on a wide range of healthcare topics

Using Clinical Outcomes to Guide Product Utilization and Control Costs

April 19, 2012

Listen_Now

The webinar was conducted in May 2012. Please note some content may be out of date.

OVERVIEW
Hospitals and healthcare systems often struggle in their efforts to reduce healthcare spending. The healthcare environment will be even more challenging in the future as providers seek to meet federal quality and safety mandates, avoid financial penalties, and deliver healthcare services that improve the health of the populations they serve.

Applying an evidence-based approach to product utilization of all kinds—including physician preference items—will be critical to every hospital’s success in achieving the triple aim of healthcare reform:

  • Improve the quality and safety of healthcare provided
  • Improve patient outcomes
  • Eliminate unnecessary costs

By incorporating unbiased evidence of efficacy and safety, operational impact, and return on investment (ROI), both clinical and financial, it is possible to change the purchasing of products and services from a price-focused, nonclinical approach to a fact-based, objective assessment, with high-quality medical care and physician buy-in as the result.

This webinar will demonstrate the practical application of using evidence to assess and compare the clinical, operational, and financial value of new and existing health technologies. By using such an approach, institutions can:

  • Influence clinical decisions with evidence
  • Realize quickly executed, non-salary cost reductions
  • Move patients to safe products
  • Improve operational and clinical efficiencies
  • Achieve sustainable savings

To illustrate the process, we will include a real-life example of managing the selection of surgical mesh products to ensure optimal patient outcomes and control costs associated with surgical hernia repair. We will review synthetic and biologic meshes, discuss factors other than specific mesh material that may affect patient outcomes, and identify the associated adverse events that have been reported to the FDA.

TARGET AUDIENCE
The target audience for this webinar includes value analysis and supply chain professionals, purchasing agents, and financial officers, as well as C-suite executives, physicians, and other clinicians interested in learning how to use a clinically driven process to evaluate health technologies based on clinical effectiveness, patient safety, operational impact, and cost.

OVERALL LEARNING PURPOSE/GOAL
The purpose of this webinar is to provide an overview of how to use evidence to guide product utilization. The goal is to demonstrate how hospitals and healthcare systems can incorporate this process into a value analysis program to deliver high-quality medical care and achieve financial savings.

LEARNING OBJECTIVES
At the conclusion of this webinar, participants should be able to:

  • Describe an evidence-based value analysis process.
  • Explain the rationale for applying an evidence-based approach to the purchasing of products and services.
  • Discuss the benefits of applying evidence to real-life situations.